Corbion N.V.
Corbion N.V. (CSNVF) Financial Performance & Income Statement Overview
Analyze Corbion N.V. (CSNVF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Corbion N.V. (CSNVF) Income Statement & Financial Overview
Explore comprehensive income reports for Corbion N.V. CSNVF, broken down by year and quarter.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $651.00M | $637.10M | $705.80M | $738.00M |
| Cost of Revenue | $491.90M | $480.70M | $525.40M | $565.70M |
| Gross Profit | $159.10M | $156.40M | $180.40M | $172.30M |
| Gross Profit Ratio | $0.24 | $0.25 | $0.26 | $0.23 |
| R&D Expenses | $23.00M | $25.00M | $21.60M | $24.40M |
| SG&A Expenses | $92.20M | $90.80M | $91.30M | $93.00M |
| Operating Expenses | $115.20M | $122.80M | $112.90M | $117.40M |
| Total Costs & Expenses | -$607.10M | $603.50M | $638.30M | $683.10M |
| Interest Income | $5.90M | $5.60M | $3.70M | $2.70M |
| Interest Expense | $13.40M | $9.30M | $21.90M | $12.90M |
| Depreciation & Amortization | $42.30M | $44.50M | $44.30M | $40.30M |
| EBITDA | $91.90M | $85.10M | $111.80M | $95.20M |
| EBITDA Ratio | $0.14 | $0.13 | $0.16 | $0.13 |
| Operating Income | $43.90M | $33.60M | $67.50M | $54.90M |
| Operating Income Ratio | $0.07 | $0.05 | $0.10 | $0.07 |
| Other Income/Expenses (Net) | -$7.70M | -$3.70M | -$22.10M | -$11.50M |
| Income Before Tax | $36.20M | $29.90M | $45.40M | $43.40M |
| Income Before Tax Ratio | $0.06 | $0.05 | $0.06 | $0.06 |
| Income Tax Expense | $9.40M | $7.20M | $1.20M | $11.20M |
| Net Income | $25.90M | $28.50M | $44.80M | $28.10M |
| Net Income Ratio | $0.04 | $0.04 | $0.06 | $0.04 |
| EPS | $0.45 | $0.49 | $0.76 | $0.48 |
| Diluted EPS | $0.45 | $0.49 | $0.75 | $0.47 |
| Weighted Avg Shares Outstanding | $58.13M | $58.73M | $59.09M | $59.03M |
| Weighted Avg Shares Outstanding (Diluted) | $58.13M | $58.73M | $59.65M | $59.79M |
Over the past four quarters, Corbion N.V. demonstrated steady revenue growth, increasing from $738.00M in Q2 2023 to $651.00M in Q4 2024. Operating income reached $43.90M in Q4 2024, maintaining a consistent 7% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $91.90M, reflecting operational efficiency. Net income dropped to $25.90M, with EPS at $0.45. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan